These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17920542)

  • 1. Corticosteroids for multiple sclerosis: I. Application for treating exacerbations.
    Frohman EM; Shah A; Eggenberger E; Metz L; Zivadinov R; Stüve O
    Neurotherapeutics; 2007 Oct; 4(4):618-26. PubMed ID: 17920542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids in the management of acute multiple sclerosis exacerbations.
    Smets I; Van Deun L; Bohyn C; van Pesch V; Vanopdenbosch L; Dive D; Bissay V; Dubois B;
    Acta Neurol Belg; 2017 Sep; 117(3):623-633. PubMed ID: 28391390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute relapses in multiple sclerosis.
    Berkovich R
    Neurotherapeutics; 2013 Jan; 10(1):97-105. PubMed ID: 23229226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in multiple sclerosis, Part 1.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Sep; 52(18):1985-2000. PubMed ID: 8528866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids in neurologic disease.
    Ellison GW
    Hosp Pract (Off Ed); 1984 Apr; 19(4):105-9, 113-5. PubMed ID: 6325480
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive treatment of multiple sclerosis.
    Carter JL; Rodriguez M
    Mayo Clin Proc; 1989 Jun; 64(6):664-9. PubMed ID: 2473360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: a review of existing therapy and future prospects.
    Khan OA
    J Pak Med Assoc; 1996 Jan; 46(1):20-4. PubMed ID: 8830165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights into corticosteroids in multiple sclerosis: war horse or chameleon?
    Krieger S; Sorrells SF; Nickerson M; Pace TW
    Clin Neurol Neurosurg; 2014 Apr; 119():6-16. PubMed ID: 24635918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corticosteroids in neurology].
    Staal A
    Ned Tijdschr Geneeskd; 1976 May; 120(18):786-92. PubMed ID: 772454
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.
    Shah A; Eggenberger E; Zivadinov R; Stüve O; Frohman EM
    Neurotherapeutics; 2007 Oct; 4(4):627-32. PubMed ID: 17920543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The symptomatic treatment of multiple sclerosis.
    Poser CM; Brinar VV
    Clin Neurol Neurosurg; 2002 Jul; 104(3):231-5. PubMed ID: 12127660
    [No Abstract]   [Full Text] [Related]  

  • 12. Long term effects of corticosteroids in multiple sclerosis in terms of the "no evidence of disease activity" (NEDA) domains.
    Saied A; Elsaid N; Azab A
    Steroids; 2019 Sep; 149():108401. PubMed ID: 31100292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis. Current concepts in management.
    Giesser B
    Drugs; 1985 Jan; 29(1):88-95. PubMed ID: 2982564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations.
    Abou Zeid N; Bhatti MT
    Neurologist; 2008 Jul; 14(4):207-23. PubMed ID: 18617847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: therapeutic update.
    Tselis AC; Lisak RP
    Arch Neurol; 1999 Mar; 56(3):277-80. PubMed ID: 10190816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in multiple sclerosis therapeutics.
    Spain RI; Cameron MH; Bourdette D
    BMC Med; 2009 Dec; 7():74. PubMed ID: 19968863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids in neurological disorders: The dark side.
    Parissis D; Syntila SA; Ioannidis P
    J Clin Neurosci; 2017 Oct; 44():1-5. PubMed ID: 28625586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal steroid therapy in neurological disease. Part I.
    Eisen AA; Norris JW
    Can Med Assoc J; 1969 Jan; 100(1):27-30. PubMed ID: 4388115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of relapses of multiple sclerosis (a review)].
    Brkovich RR; Totolian NA; Sokolov AIu; Ignatov IuD; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):69-77. PubMed ID: 24416811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.